Endocrine & Metabolism Research Institute (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Endocrine & Metabolism Research Institute" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

low place

low place

5^th place

5^th place

195^th place

302^nd place

1osteofound.org

low place

low place

68^th place

117^th place

2^nd place

2^nd place

1web.archive.org

1^st place

1^st place

1eurekalert.org

3,538^th place

3,083^rd place

doi.org

Hasani-Ranjbar, Shirin; Jouyandeh, Zahra; Qorbani, Mostafa; Hemmatabadi, Mahbubeh; Larijani, Bagher (December 2012). "The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients". DARU Journal of Pharmaceutical Sciences. 20 (1): 84. doi:10.1186/2008-2231-20-84. ISSN 2008-2231. PMC 3556013. PMID 23351359.

eurekalert.org

"IOF CNS Medal awarded to professor Bagher Larijani". EurekAlert!. Retrieved 2021-06-01.

europa.eu

cordis.europa.eu

"PoC in-office device for identifying individuals at high risk of Osteoporosis and osteoporotic fracture". European commission. 1 October 2017.

nih.gov

ncbi.nlm.nih.gov

Bakhshayeshi, S.; Madani, SP.; Hemmatabadi, M.; Heshmat, R.; Larijani, B. (2011). "Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial". DARU: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 19 (1): 65–70. ISSN 1560-8115. PMC 3232074. PMID 22615641.
Hasani-Ranjbar, Shirin; Jouyandeh, Zahra; Qorbani, Mostafa; Hemmatabadi, Mahbubeh; Larijani, Bagher (December 2012). "The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients". DARU Journal of Pharmaceutical Sciences. 20 (1): 84. doi:10.1186/2008-2231-20-84. ISSN 2008-2231. PMC 3556013. PMID 23351359.

pubmed.ncbi.nlm.nih.gov

Bakhshayeshi, S.; Madani, SP.; Hemmatabadi, M.; Heshmat, R.; Larijani, B. (2011). "Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial". DARU: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 19 (1): 65–70. ISSN 1560-8115. PMC 3232074. PMID 22615641.
Hasani-Ranjbar, Shirin; Jouyandeh, Zahra; Qorbani, Mostafa; Hemmatabadi, Mahbubeh; Larijani, Bagher (December 2012). "The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients". DARU Journal of Pharmaceutical Sciences. 20 (1): 84. doi:10.1186/2008-2231-20-84. ISSN 2008-2231. PMC 3556013. PMID 23351359.

osteofound.org

"Endocrinology and Metabolism Research Center". International Osteoporosis Foundation. 2004-04-11.

tums.ac.ir

emri.tums.ac.ir

"Collaboration with World Health Organization". Endocrinology & Metabolism Research Institute.
"Collaboration with International Osteoporosis Foundation". Endocrinology & Metabolism Research Institute.

web.archive.org

"NCDs | UNIATF Awards 2018". WHO. Archived from the original on September 24, 2018. Retrieved 2021-06-01.

who.int

apps.who.int

"WHO Collaborating Centre for Research and Education on Management of Osteoporosis and Diabetes". WHO Collaborating Centres.

who.int

"NCDs | UNIATF Awards 2018". WHO. Archived from the original on September 24, 2018. Retrieved 2021-06-01.

worldcat.org

search.worldcat.org

Bakhshayeshi, S.; Madani, SP.; Hemmatabadi, M.; Heshmat, R.; Larijani, B. (2011). "Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial". DARU: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 19 (1): 65–70. ISSN 1560-8115. PMC 3232074. PMID 22615641.
Hasani-Ranjbar, Shirin; Jouyandeh, Zahra; Qorbani, Mostafa; Hemmatabadi, Mahbubeh; Larijani, Bagher (December 2012). "The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients". DARU Journal of Pharmaceutical Sciences. 20 (1): 84. doi:10.1186/2008-2231-20-84. ISSN 2008-2231. PMC 3556013. PMID 23351359.